And Canada was slow to put in place physical distancing measures that might have made up for that shortfall. When the virus began circulating early in 2020, many of these companies restricted supply of the chemicals and other components that comprise COVID-19 tests to home markets. The result was that Canadian health authorities were not able to contain the virus when it mattered most, or mitigate its effects with precision until it was too late.įredericton-based LuminUltra, a specialist in testing for environmental pathogens, supplied Canada’s government laboratories with chemicals they used to devise COVID-19 tests. But the labs were never set up to achieve the kinds of volumes that would match the rapid spread of the virus. The industry that builds molecular testing devices is dominated by a dozen or so multinationals, none of them Canadian. Not only that, the medical devices directorate at Health Canada is every week analyzing ever more sophisticated tests that can simultaneously identify flu, COVID-19 and other infectious diseases, and be performed at home.ĭoes it really matter that nearly all of these tests, too, have been developed by foreign-based enterprises? Canada finally has the COVID-19 tests it requires to safely re-open schools, borders, offices and entertainment venues. Article contentĪt first glance, this seems an acceptable result.
This advertisement has not loaded yet, but your article continues below.
National Capital Region's Top Employers.
0 kommentar(er)
